Embla Medical hf
CSE:EMBLA

Watchlist Manager
Embla Medical hf Logo
Embla Medical hf
CSE:EMBLA
Watchlist
Price: 35.3 DKK 2.32% Market Closed
Market Cap: 15.1B DKK
Have any thoughts about
Embla Medical hf?
Write Note

Gross Margin
Embla Medical hf

62%
Current
62%
Average
47.1%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
62%
=
Gross Profit
521.1m
/
Revenue
840.3m

Gross Margin Across Competitors

Country IS
Market Cap 15.1B DKK
Gross Margin
62%
Country US
Market Cap 199B USD
Gross Margin
56%
Country US
Market Cap 191.3B USD
Gross Margin
67%
Country US
Market Cap 141.3B USD
Gross Margin
64%
Country US
Market Cap 134.2B USD
Gross Margin
69%
Country IE
Market Cap 104.6B USD
Gross Margin
65%
Country US
Market Cap 65.6B USD
Gross Margin
45%
Country DE
Market Cap 58.1B EUR
Gross Margin
38%
Country US
Market Cap 44.5B USD
Gross Margin
79%
Country CN
Market Cap 311.1B CNY
Gross Margin
64%
Country US
Market Cap 36.3B USD
Gross Margin
41%
No Stocks Found

Embla Medical hf
Glance View

Market Cap
15.1B DKK
Industry
Health Care

Embla Medical hf, a rising star in the medical device industry, has carved a niche in the sleep diagnostics sector with its innovative technology. Founded with the vision of transforming sleep health, the Iceland-based company specializes in developing advanced sleep diagnostic systems. These devices are crucial in identifying sleep disorders, a growing concern globally as awareness about sleep health continues to rise. Embla Medical’s flagship products are portable and user-friendly diagnostic tools that allow both clinicians and patients to monitor sleep patterns in real-time. By focusing on cutting-edge technology and accuracy, the company has established itself as a trusted partner in medical facilities worldwide, enhancing its reputation and solidifying its market presence. The business model of Embla Medical relies heavily on the research and development of its diagnostic systems, complemented by a strategic emphasis on customer service and support. The revenue stream is generated through the sale of these sophisticated devices to hospitals, sleep clinics, and directly to healthcare providers. Additionally, they offer ongoing maintenance services and software updates, providing a continuous source of income post-sale. By integrating software with hardware, they ensure that their equipment remains at the forefront of technological advancements in sleep diagnostics. This not only drives sales but also builds a loyal customer base that places high value on efficacy and ease of use. Embla Medical's focus on innovation and customer satisfaction positions them well to capitalize on the growing market for sleep healthcare solutions.

EMBLA Intrinsic Value
38.64 DKK
Undervaluation 9%
Intrinsic Value
Price

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
62%
=
Gross Profit
521.1m
/
Revenue
840.3m
What is the Gross Margin of Embla Medical hf?

Based on Embla Medical hf's most recent financial statements, the company has Gross Margin of 62%.